Skip Ribbon Commands
Skip to main content
Home Sign In Register
img img
 

 Announcements

 

Title

Fraudulent Health Claims

Body

It has come to the notice of the Food and Drugs Board (FDB), through its post market surveillance activities, that some unscrupulous people are operating illegal treatment schemes in some parts of country, particularly the Brong Ahafo and Ashanti Regions, using food supplements for the treatment of disease conditions.
These so-called health facilities/clinics are engaged in fraudulent diagnosis using unapproved/uncertified medical devices and ‘treating’ their patients with food supplements imported and distributed by Dynapharm Company Ghana Limited.
Some of the diseases that they claim to treat with their food supplements include: Cancers, Heart Diseases, Diabetes, Parkinson Diseases, Epilepsy, Reproductive Disorders, Allergies, Asthma, Hepatitis, Kidney Problems, etc
The FDB wishes to caution the general public to desist from patronizing these fake treatment schemes involving the use of food supplements as medicines to treat diseases; and not to allow themselves to be subjected to such treatment scams.
The food supplements being fraudulently used include but not limited to Red Coffee with Ginseng, Ganoderma, Dyna Serenoa, Spirulina Tablets, Nonicare Instant Cereal, Noni Plus Tea, Dyna RH Capsules, Pro Young, Dyna Tonic, Yee Yang Yen and Wheat Grass Extract Powder.
The FDB further reiterates that food supplements are not medicines and therefore have no therapeutic indications. Their wrongful use to ‘treat’ disease conditions can result in worsening of the disease condition which can even lead to death in some cases.

 

The public is being entreated to report anyone or health facility involved in such fraudulent treatment schemes to any FDB office countrywide or any of the following numbers;
0208204968,
0544338829,
0244337235
0246809509.
 
John Odame-Darkwah

 

Deputy Chief Executive (Food)

 

For: Chief Executive

 


Site best viewed in Internet Explorer 7 or above, Firefox 3.6 or above, Google Chrome 19 or above, Safari 5.0 +, with screen resolution of 1024*768 & above.